Hydramacin-1 in action: scrutinizing the barnacle model

Antimicrob Agents Chemother. 2013 Jul;57(7):2955-66. doi: 10.1128/AAC.02498-12. Epub 2013 Apr 15.

Abstract

Hydramacin-1 (HM1) from the metazoan Hydra exerts antimicrobial activity against a wide range of bacterial strains. Notably, HM1 induces the aggregation of bacterial cells, accompanied by precipitation. To date, the proposed mechanism of peptide-lipid interaction, termed the barnacle model, has not been described on the molecular level. Here, we show by biochemical and biophysical techniques that the lipid-peptide interactions of HM1 are initiated by electrostatic and hydrophobic effects, in particular, by tryptophan and neighboring polar amino acid residues that cause an interfacial localization of the peptide between two self-contained lipid bilayers. The high binding constants of HM1 upon lipid interaction are in the range of other potent antimicrobial peptides, e.g., magainin, and can be reasonably explained by two distinct epitopes on the surface of the peptide's global structure, which both contain SWT(K/R) motifs. The residues of this motif favor localization of the peptide in the head group region of phospholipid bilayers up to a penetration depth of 4 Å and a minor participation of the lipids' hydrocarbon regions. Our results expand the knowledge about the molecular modes of action antimicrobial peptides use to tackle their target cells. Furthermore, the aggregation of living bacteria by HM1 was observed for a broad range of Gram-positive and Gram-negative bacteria. Therefore, the detailed view of peptide-lipid interactions described by the barnacle model consolidates it among the established models.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology*
  • Antimicrobial Cationic Peptides / chemistry
  • Antimicrobial Cationic Peptides / metabolism
  • Antimicrobial Cationic Peptides / pharmacology*
  • Bacteria / drug effects*
  • Bacteria / metabolism
  • Burkholderia cepacia / drug effects
  • Burkholderia cepacia / metabolism
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism*
  • Escherichia coli / drug effects
  • Escherichia coli / metabolism
  • Hydrophobic and Hydrophilic Interactions
  • Lipid Bilayers / chemistry
  • Lipid Bilayers / metabolism*
  • Lipids
  • Protein Binding
  • Proteus mirabilis / drug effects
  • Proteus mirabilis / metabolism
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / metabolism
  • Staphylococcus haemolyticus / drug effects
  • Staphylococcus haemolyticus / metabolism
  • Staphylococcus hominis / drug effects
  • Staphylococcus hominis / metabolism
  • Static Electricity
  • Streptococcus pneumoniae / drug effects
  • Streptococcus pneumoniae / metabolism

Substances

  • Anti-Bacterial Agents
  • Antimicrobial Cationic Peptides
  • Lipid Bilayers
  • Lipids
  • hydramacin-1, Hydra magnipapillata